Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
38%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
24%
ALSO IN MEDX
MEDX
28
HOLDINGS
43%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 7.0% | 8.8% | 7.0% | |
BRISTOL-MYERS SQUIBB CO | 6.3% | 5.2% | 5.2% | |
JOHNSON & JOHNSON | 7.4% | 4.8% | 4.8% | |
PFIZER INC | 7.4% | 4.0% | 4.0% | |
AMGEN INC | 3.6% | 5.9% | 3.6% |
FTXH Overweight Relative to MEDX
GILEAD SCIENCES INC | 3.9% | |
ZOETIS INC | 3.8% | |
VIATRIS, INC. | 3.7% | |
UNITED THERAPEUTICS CORP | 3.6% | |
MERCK & CO. INC. | 3.6% | |
PFIZER INC | 3.4% | |
JAZZ PHARMACEUTICALS PLC | 3.0% | |
JOHNSON & JOHNSON | 2.6% | |
EXELIXIS INC | 2.4% | |
ELANCO ANIMAL HEALTH, INC. | 2.4% |
FTXH Underweight Relative to MEDX
ELI LILLY & CO | -13.0% | |
NOVARTIS AG-ADR | -7.3% | |
ASTRAZENECA PLC-SPONS ADR | -5.5% | |
ALNYLAM PHARMACEUTICALS INC | -5.1% | |
CRISPR THERAPEUTICS AG | -3.2% | |
ALKERMES PLC | -3.1% | |
IONIS PHARMACEUTICALS, INC. | -3.1% | |
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% | |
AMGEN INC | -2.2% | |
ABBVIE INC | -1.8% |